ORUKA
Live / Applied — First extension granted (statement of use) (as of 12 Dec 2025)
What this means for you
Not registered yet, but its 15 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98649557
- Mark type
- Stylized text
- Filed
- 15 Jul 2024
- Published for opposition
- 22 Apr 2025
- Attorney of record
- Nichole T. Hayden
Goods and services
- Class 001 — Chemicals: Biochemical preparations for scientific purposes, namely, in vitro scientific or research use; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
- Class 005 — Pharmaceuticals: Biologics in the nature of pharmaceutical preparations for treatment of chronic skin diseases such as plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications; Antibodies for medical purposes, namely, for treatment of chronic skin diseases such as plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications; Therapeutic pharmaceutical for the treatment of chronic skin diseases such as plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications
- Class 042 — Scientific and technological services: Biotechnology research related to antibodies and therapies for treatment of chronic skin diseases such as plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications
Owner
- Oruka Therapeutics, Inc., Menlo Park, CA, US
- Oruka Therapeutics, Inc., Menlo Park, CA, US
Prosecution history
- 17 Dec 2025 — TEAS STATEMENT OF USE RECEIVED
- 13 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Dec 2025 — SOU EXTENSION 1 GRANTED
- 12 Dec 2025 — SOU EXTENSION 1 FILED
- 12 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Apr 2025 — PUBLISHED FOR OPPOSITION
- 16 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Jan 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Jan 2025 — NON-FINAL ACTION E-MAILED